- ￥500
- MedChemExpress(MCE)
- 中国
- HY-B2144A-1g
- 2025年07月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
广州威佳科技有限公司
- CAS号：
9012-76-4
- 规格：
1g
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验TRICINE GELS Protocol (For Low MW proteins (
Stock Solutions1) Gel Buffer: 3 M TrisHCl pH8.45 + 0.3% SDS. Keep RT. (Prepare: 18.15gr Tris + 150mg SDS + H2O up to 50ml. Adjust pH before you add the SDS) 2) 40% Acrylamide solution 29:1 (Acrylamide 29 / Methylene bis Acrylamide 1) or 40
TRICINE GELS Protocol (For Low MW proteins (
Stock Solutions1) Gel Buffer: 3 M TrisHCl pH8.45 + 0.3% SDS. Keep RT. (Prepare: 18.15gr Tris + 150mg SDS + H2O up to 50ml. Adjust pH before you add the SDS) 2) 40% Acrylamide solution 29:1 (Acrylamide 29 / Methylene bis Acrylamide 1) or 40
Chitosan-Based Nanoparticles as Delivery Systems of Therapeutic Proteins
route remains as a primary strategy for protein administration essentially due to its specific physicochemical properties. However, the research on alternative nonparenteral delivery routes continues. The high molecular weight (MW), hydrophilicity
技术资料暂无技术资料 索取技术资料
